معرفی
Megan Kassick, MD, MPH is an Assistant Professor in the Department of Radiation Oncology at the Perelman School of Medicine, University of Pennsylvania. She is actively involved in global oncology with a focus on improving access to cancer care in low-resource settings, particularly in Sub-Saharan Africa. Her clinical work centers on gynecologic and breast malignancies, with specialization in brachytherapy and image-guided radiotherapy.
Her research interests span global oncology, cervical cancer disparities, implementation science, and women's health. She has led qualitative studies in Zambia to understand delays in cervical cancer treatment and barriers to adopting advanced radiotherapy techniques. Her work is closely aligned with international efforts, including collaborations with the International Atomic Energy Agency (IAEA) on coordinated research projects.
The recent publications highlight a consistent focus on strengthening global radiation oncology infrastructure, addressing pandemic-related disruptions, and ensuring sustainable interventions in resource-limited regions. Themes across her work include health systems resilience, equity in cancer care, and translational implementation research.
Scientific Awards:
- No awards explicitly mentioned in the text.
Advising and Grants:
While formal advisees are not listed, Dr. Kassick is engaged in global health mentorship and training programs at Penn. She participates in the Global Health Year-out Program and mentors students and trainees in global oncology. Her research has been supported through institutional and international collaborations, including projects funded or facilitated by the IAEA. She also contributes to curriculum development and training in global radiation oncology.
Labs and Teams:
Dr. Kassick is a member of the Women's Health Service at Penn and collaborates with multidisciplinary teams in radiation oncology and global health. She works closely with the Center for Global Health at Penn and is involved in regional engagement initiatives in Africa, particularly Zambia. Her team includes international oncologists, public health researchers, and implementation scientists focused on improving cancer outcomes in underserved populations.
